Related Experiment Video
Updated: Jun 8, 2026
Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes
Khurram Shahzad1, Quratul Ain Aziz, Jean-Paul Leva
1Department of Medicine, Division of Cardiology, Columbia University, New York, New York 10032, USA.
Insights
Unexplained graft dysfunction (GD) after heart transplantation (HTx) significantly increases mortality. New diagnostic tools are crucial for identifying this severe condition and improving patient outcomes in heart transplant recipients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Graft dysfunction (GD) is a critical complication following heart transplantation (HTx), contributing significantly to patient morbidity and mortality.
- The specific impact of various pathophysiologic mechanisms underlying GD on long-term outcomes remains incompletely understood.
Purpose of the Study:
- To determine the incidence of GD after heart transplantation.
- To compare the clinical outcomes associated with different histopathologic mechanisms of rejection causing GD.
Main Methods:
- A retrospective analysis of 1,099 heart transplant recipients from January 1994 to March 2008 was conducted.
- Patients hospitalized with new-onset GD were categorized based on histopathology: unexplained (GD-U), antibody-mediated rejection (GD-AMR), cardiac allograft vasculopathy (GD-CAV), and acute cellular rejection (GD-ACR).
- In-hospital and 3-, 6-, and 12-month mortality rates were compared across groups using chi-square and log-rank tests.
Main Results:
- Of 126 patients with GD, 100 had complete histology data, with 21 in GD-U, 20 in GD-AMR, 27 in GD-CAV, and 32 in GD-ACR.
- In-hospital mortality rates were notably higher in the unexplained GD group (52%) compared to GD-AMR (20%), GD-CAV (15%), and GD-ACR (6%) (p = 0.0006).
- Survival rates at 3, 6, and 12 months were significantly lower for patients with unexplained GD.
Conclusions:
- A substantial subset of heart transplant recipients experiencing new-onset graft dysfunction presents with histopathologically unexplained causes.
- Unexplained graft dysfunction is strongly associated with a significantly elevated mortality risk.
- Development of novel diagnostic tools is imperative for better characterization and prediction of this adverse clinical phenotype.
Background:
Graft dysfunction (GD) after heart transplantation (HTx) is a major cause of morbidity and mortality. The impact of different pathophysiologic mechanisms on outcome is unknown. In this large, single-center study we aimed to assess the incidence of GD and compare the outcomes with different histopathologic mechanisms of rejection.
Methods:
We analyzed a data set of 1,099 consecutive patients after their HTx at Columbia University Medical Center between January 1994 and March 2008, and identified all patients hospitalized with new-onset GD. Based on the histopathologic data, patients were divided into GD-unexplained (Group-GD-U), GD-antibody-mediated rejection (Group-GD-AMR), GD-cardiac allograft vasculopathy (Group-GD-CAV) and GD-acute cellular rejection (Group-GD-ACR) groups. We compared the in-hospital and 3-, 6- and 12-month mortality across these groups using the chi-square test. We also compared the 3-, 6- and 12-month survival curves across groups using the log-rank test.
Results:
Of 126 patients (12%) identified with GD, complete histology data were available for 100 patients. There were 21, 20, 27 and 32 patients identified in Group-GD-U, Group-GD-AMR, Group-GD-CAV and Group-GD-ACR, respectively. The in-hospital mortality rates were 52%, 20%, 15% and 6%, respectively. The in-hospital mortality rate was significantly higher in Group-GD-U compared with all other groups (p = 0.0006). The 3-, 6- and 12-month survival rate was also significantly lower in Group-GD-U compared with all other groups.
Conclusion:
A significant proportion of patients presenting with new-onset GD have unexplained histopathology. Unexplained GD is associated with a significantly higher mortality rate. New diagnostic tools are necessary to better understand and detect/predict this malignant phenotype.
More Related Videos
Related Concept Videos
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction